UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052993
Receipt number R000060459
Scientific Title Evaluation of listening performance in quiet and noisy conditions in unilateral cochlear implant users
Date of disclosure of the study information 2024/04/01
Last modified on 2023/12/04 16:15:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of listening performance in quiet and noisy conditions in unilateral cochlear implant users

Acronym

Evaluation of listening performance in unilateral cochlear implant users

Scientific Title

Evaluation of listening performance in quiet and noisy conditions in unilateral cochlear implant users

Scientific Title:Acronym

Evaluation of listening performance in unilateral cochlear implant users

Region

Japan


Condition

Condition

bilateral sensorineural hearing loss

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine the extent to which speech perception from the non-wearing side (or the non-wearing ear in bilateral wearers) is affected by noise from the wearing side in unilateral and bilateral cochlear implant wearers.

Basic objectives2

Others

Basic objectives -Others

Changes in hearing performance when wearing supplemental hearing aids or bilateral hearing aids.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Word discrimination in noise

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Cross-Auditory System

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients between the ages of 18 and 75 years old with bilateral profound sensorineural hearing loss and cochlear implantation
Cochlear implant users who have had a cochlear implant for at least 3 months.
The patient developed severe to profound bilateral sensorineural hearing loss after language acquisition.
The patient's first language is Japanese.

Key exclusion criteria

Cochlear implants are worn for less than 3 hours per day.
Hearing loss before language acquisition
The patient's first language is a foreign language.
Other conditions that the physician determines are not appropriate for this study

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Tadao
Middle name
Last name Yoshida

Organization

Nagoya university

Division name

Medicine, Otorhinolaryngology

Zip code

466-8550

Address

65, Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan

TEL

052-744-2323

Email

tadaoy@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Tadao
Middle name
Last name Yoshida

Organization

Nagoya university

Division name

Medicine, Otorhinolaryngology

Zip code

466-8550

Address

65, Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan

TEL

052-744-2323

Homepage URL


Email

tadaoy@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University

Institute

Department

Personal name



Funding Source

Organization

Other

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Advanced Bionics, Inc.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Department of Ethics Review Committee

Address

65, Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan

Tel

0527442323

Email

ethics@med.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 03 Month 01 Day

Date of IRB


Anticipated trial start date

2024 Year 04 Month 01 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 12 Month 04 Day

Last modified on

2023 Year 12 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060459


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name